A5035947982- Pharmaceutical Economics and Policy
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical studies and practices
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical industry and healthcare
- Healthcare Systems and Technology
- Healthcare Policy and Management
- Primary Care and Health Outcomes
- Electronic Health Records Systems
- Antibiotic Use and Resistance
- Economic and Financial Impacts of Cancer
- Pharmaceutical Quality and Counterfeiting
- Global Maternal and Child Health
- Menopause: Health Impacts and Treatments
- Estrogen and related hormone effects
- Global Public Health Policies and Epidemiology
- Child and Adolescent Health
- Healthcare cost, quality, practices
- Bone health and osteoporosis research
- Patient Safety and Medication Errors
- Public Health Policies and Education
- Medication Adherence and Compliance
- Climate Change Communication and Perception
- Acute Lymphoblastic Leukemia research
- Medical Research and Practices
University of Newcastle Australia
2011-2021
World Health Organization Regional Office for Europe
2019-2021
The University of Melbourne
2020
Austin Health
2020
Peninsula Health
2020
Eastern Health
2020
Monash Health
2020
Monash University
2020
University of Glasgow
2020
Australian Catholic University
2020
To examine, for essential anti-cancer medicines, the alignment of national lists medicines and reimbursable with World Health Organization's (WHO's) Model Lists.National medicine 135 countries per-capita gross incomes below 25 000 United States dollars in 2015 were compared WHO's 2013 Lists Essential Medicines. Correlations between numbers included income (GNI), government health expenditure number physicians per 1000 population evaluated.Of on List 16 added via revision List, 0-25 (median:...
The burden of patients with heart failure on health care systems is widely recognised, although there have been few attempts to quantify individual patterns and differences in service utilisation related age, socio-economic factors the presence co-morbidities. aim this study was assess typical profile, trajectory resource use a cohort Australian using linked population-based, patient-level data. Using hospital separations (Admitted Patient Data Collection) death registrations (Registry...
Introduction Surveillance of antimicrobial medicines consumption is central to improving their use and reducing resistance rates. There are few published data on antibiotic in Eastern Europe Central Asia. To address this, 18 non-European Union (EU) countries territories contribute the WHO Regional Office for (WHO Europe) Antimicrobial Medicines Consumption (AMC) Network. Objectives (i) Analyse 2015 J01 class antibacterials systemic from 16 AMC Network members; (ii) compare results with 2011...
Background: Surveillance of antimicrobial consumption (AMC) is important to address inappropriate use. AMC data for countries in the European Union (EU) and Economic Area (EEA) Eastern Central Asian were compared provide future guidance. Methods: Analyses 2014–2018 from 30 EU/EEA Antibiotic Consumption network (ESAC-Net) 15 WHO Regional Office Europe (WHO Europe) Network conducted using Anatomical Therapeutic Chemical (ATC) classification Defined Daily Dose (DDD) methodology. Total (DDD per...
Objective To document the inclusion of key medicines for children in national essential lists (EMLs) and standard treatment guidelines, to assess availability cost these 14 countries central Africa.Methods Surveys were conducted 12 public private sector medicine outlets each country's capital city.Data collected on survey day patient lowest priced stock.Findings The proportion EMLs ranged from 50% 90%.In only three more than such available medical stores (range: 15-75%).Availability...
Background Most maternal and child deaths are preventable or treatable with proven, cost-effective interventions for infectious diseases neonatal complications. In 2015 sub-Saharan Africa accounted up to 66% of global half the under-five deaths. Access essential medicines commodities trained healthcare workers provide life-saving maternal, newborn post-natal care central further reductions in mortality. Methods Available data 24 priority women children were extracted from WHO service...
Universal Health Coverage is key to reach the overall health-related Sustainable Development Goal, and within this, access safe, effective, quality, affordable essential medicines critical. Currently, for noncommunicable diseases in many countries are not available when needed if they present, unaffordable. Countries face challenges of rising prevalence due increasing risk factors ageing populations, along with under-diagnosis under-treatment. Providing disease only one piece a complex...
To test the effect of a AU dollars 2 scratch lottery ticket on response rates to national mailed questionnaire Australian general practitioners (GPs) and medical specialists.A randomized controlled trial was conducted incentive sent half participants with first mailing. A single follow-up mailing without all non-respondents. Survey respondents were then informed research question regarding incentives allowed withdraw their study data. Differences in between doctors receiving not incentive,...
To determine levels of public awareness consumer adverse drug reaction (ADR) reporting systems in Australia.Cross-sectional study conducted 2012 residents the Hunter Valley region New South Wales, who participated a computer-assisted telephone interview (CATI), and national sample, completed an online Pureprofile survey.Proportion respondents experiencing ADRs; type medicine involved; whether participants reported event to whom; use existing ADR mechanisms.There were 2484 CATI 2497...
In response to the global burden of non-communicable diseases (NCDs), World Health Organization (WHO) has developed a Global Action Plan that includes voluntary medicines target 80% availability and affordability essential for prevention treatment diabetes, cardiovascular disease respiratory both in public private health facilities. Reliable measures are needed track progress towards meeting this target. The results three studies measuring hypertension diabetes conducted Tanzania 2012–2013...
The Essential Medicines Working Group of the International Society Pediatric Oncology (SIOP) has proposed a list antineoplastic drugs that should be available in low and middle income countries.Data were extracted on listing 18 essential 8 ancillary medicines national lists (NEMLs) or reimbursable (NRMLs) 135 countries with gross (GNI) per capita less than US $25,000. Correlations between numbers listed GNI capita, annual government health expenditure (AGHE) number physicians million people...
David Henry and colleagues review Australian news stories over a five-year period to assess whether quality is associated with who wrote the story: specialist health journalist or non-specialist.
Pressures to include more cancer medicines in the WHO Model List of Essential Medicines (EML) pose challenges for Expert Committee responsible recommending changes list. How do fit within a definition essential as those meeting priority health needs population? Will identifying medicine "essential" offer some leverage improve access effective low and middle-income countries (LMICs)? The addition number treatment cancers children Children (EMLc) 2011 provides important insights into previous...
David Henry and colleagues examine compliance with new disclosure requirements of Medicines Australia, the pharmaceutical industry representative body, argue that they fall short instead more comprehensive reporting standards are needed.
Investments in eHealth worldwide have been mirrored Australia, with >90% of general practices computerized. Recent incentives promote the use up to date electronic information sources relevant practice flexibility mode access.
This year, the Expert Committee for Selection and Use of Medicines will consider requests to include high-cost medicines can -cer, hepatitis C, multidrug-resistant tu -berculosis new oral anticoagulants on model list. These applications challenge perceptions essential medi -cines raise questions about how address issues cost affordability countries when making decisions at global level.Essential are those that satisfy priority health-care needs population.